# Optometry Times - Clinical News & Expert Optometrist Insights

> Optometry Times - Clinical News & Expert Optometrist Insights - Healthcare Publication

- Base URL: https://www.optometrytimes.com
- Generated: 2026-10-20T19:52:42.017Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.optometrytimes.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.optometrytimes.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.optometrytimes.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.optometrytimes.com/robots.txt](https://www.optometrytimes.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Blog](https://www.optometrytimes.com/blog)
- [Clinical](https://www.optometrytimes.com/clinical)
- [Conference](https://www.optometrytimes.com/conference)
- [Conference](https://www.optometrytimes.com/conference)
- [Expert Interviews](https://www.optometrytimes.com/media/expert-interviews)
- [Insights](https://www.optometrytimes.com/insights)
- [MJH Broadcast Channel](https://www.optometrytimes.com/mjh-broadcast-channel)
- [News](https://www.optometrytimes.com/news)
- [Practice Ownership](https://www.optometrytimes.com/media/practice-ownership)
- [Publications](https://www.optometrytimes.com/publications)
- [Sponsored Resources](https://www.optometrytimes.com/sponsored-resources)
- [Video Series](https://www.optometrytimes.com/video-series)
- [Viewpoints](https://www.optometrytimes.com/viewpoints)
- [What’s Your WhEYE?](https://www.optometrytimes.com//whats-your-wheye)

## Featured Content

- [Duravyu for wet AMD misses primary end point in phase 3 LUCIA trial](https://www.optometrytimes.com/view/duravyu-wet-amd-misses-primary-end-point-in-phase-3-lucia-trial): Duravyu gained 2.5 letters vs 6.1 with aflibercept at week 52/56, missing noninferiority in a second phase 3 wet AMD trial.
- [FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours](https://www.optometrytimes.com/view/fda-approves-brytly-eye-drops-for-ocular-redness-relief): Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness.
- [Missed AAOpt 2026? Here are the highlights by specialty](https://www.optometrytimes.com/view/missed-aaopt-2026-highlights-by-specialty): From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. 
- [FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia](https://www.optometrytimes.com/view/fda-approves-phentolamine-ophthalmic-solution-0-75-ryzumvi-for-presbyopia): Ryzumvi gained a presbyopia indication in adults based on the phase 3 VEGA-2 and VEGA-3 trials, adding a pharmacologic option for managing near vision...
- [FDA approves subcutaneous Enspryng for TED](https://www.optometrytimes.com/view/fda-approves-subcutaneous-enspryng-for-ted): Enspryng is the first subcutaneous, at-home treatment option for TED and the first interleukin (IL)-6 receptor inhibitor approved in the indication.
- [AAOpt 2026: Keeping up with contact lens care as technology advances](https://www.optometrytimes.com/view/aaopt-2026-keeping-up-with-contact-lens-care-as-technology-advances): Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologie...
- [2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery](https://www.optometrytimes.com/view/2026-nobel-prize-physiology-or-medicine-awarded-optogenetics-discovery): Three researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease.
- [A rapid fire look at research presented at AAOpt26](https://www.optometrytimes.com/view/a-rapid-fire-look-at-research-presented-at-aaopt-2026): Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
- [FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee](https://www.optometrytimes.com/view/faq-what-clinicians-should-know-as-syd-101-heads-to-fda-advisory-committee): FDA advisers review SYD-101, low-dose atropine 0.01% for pediatric myopia, on Oct 30 after a 2025 complete response letter.
- [The Independent Advantage S02 E06: Taking the strain of undesirable tasks off staff with AI](https://www.optometrytimes.com/view/the-independent-advantage-s02-e06-taking-the-strain-of-undesirable-tasks-off-staff-with-ai): For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the bur...

## Feeds and Indexes

- [RSS Feed](https://www.optometrytimes.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.optometrytimes.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.optometrytimes.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.optometrytimes.com/authors): Browse all contributors and their published work